The Cost of NOT Appealing an Insurance Denial: What You Stand to Lose

Fewer than 1 in 500 denied claims are ever appealed — less than 0.2%, according to KFF data from ACA marketplace plans. Yet when people do appeal, 40–60% of External Independent Review: Complete Guide" class="auto-link">external reviews overturn the denial. Put these two numbers together and the picture is clear: insurance companies deny billions of dollars in claims every year, knowing that almost nobody will fight back. The cost of not appealing is not just the dollar amount on the denial letter — it is the cumulative financial, medical, and long-term toll of accepting a decision that was often wrong in the first place.

Why Insurers Count on You Not Appealing

Insurance denials are frequently generated by algorithms that flag claims based on cost thresholds, diagnosis codes, and utilization patterns — not individual clinical review. KFF data shows that ACA marketplace insurers denied approximately 17% of in-network claims. Of those denials, only 0.2% were ever appealed. If even 10% of denied claims were appealed, and 50% of those appeals succeeded, insurers would pay out billions more annually. The entire denial economy depends on patient inertia.

Not medically necessary denials are often algorithmic. The same treatment that a human reviewer would approve is flagged automatically by cost-management software. When a human actually reviews the clinical documentation on appeal, the denial is frequently reversed.

Experimental classification denials are sometimes applied broadly to FDA-approved treatments with strong clinical evidence. External reviewers with actual specialty expertise in the relevant field overturn these at high rates.

Step therapy denials often proceed without anyone actually reviewing whether the required step therapy drugs are contraindicated or were already tried. Documenting prior treatment history frequently resolves these denials at the internal appeal level.

How to Appeal When You Think You Cannot Win

Step 1: Read the Denial Letter with Fresh Eyes

The denial letter is a roadmap for your appeal, not a final verdict. Identify the specific denial reason and the policy provision cited. Every criterion the insurer claims you do not meet is a criterion your appeal must address directly. Under ERISA (29 U.S.C. § 1133) and ACA regulations (45 CFR 147.136), insurers must provide specific reasons for every denial — use those reasons as your point-by-point rebuttal structure.

Step 2: Calculate the Expected Value of Appealing

For a $30,000 surgical denial at a 50% success rate, the expected value of a free appeal is $15,000. For a $10,000 medication denial, the expected value at 40% success is $4,000. The appeal costs $0. The expected value is always positive because the cost of not appealing is the full amount of the denied claim, while the cost of appealing is zero. There is no financial scenario where not appealing is the rational choice.

Step 3: Understand the Medical Cost of Delay

A 2023 study in the Journal of Clinical Oncology found that each month of delay in cancer treatment is associated with a 1–3% increase in mortality. Delayed hernia repair risks incarceration requiring emergency surgery at 3–5 times the cost. Untreated chronic conditions (diabetes, autoimmune diseases, heart failure) lead to complications and hospitalizations costing 5–10 times the denied treatment cost. These medical consequences of not appealing compound the financial ones.

Step 4: File the Appeal Now, Not Later

Internal appeals typically must be filed within 180 days of the denial. External reviews have a 4-month window after internal appeal denial in most states. If you wait and miss these deadlines, you forfeit your right to appeal entirely. The urgency is real — file immediately using ClaimBack to generate your letter in under 30 minutes.

Step 5: Use the Free External Review if the Internal Appeal Fails

External review is free under ACA regulations (45 CFR 147.138) and results in a binding decision from an independent reviewer. This reviewer is not employed by your insurer and applies objective clinical standards. In California, the DMHC overturn rate for external reviews is approximately 60%. In New York, the DFS reports 57% of external reviews favor the patient. These numbers represent real recoveries for real patients who fought back.

Step 6: File a State Complaint Simultaneously

Filing a complaint with your state insurance commissioner costs nothing and creates accountability. States with robust consumer assistance programs — California, New York, Illinois, Texas — have higher appeal rates and higher overturn rates because patients get support navigating the process. A state complaint can sometimes accelerate internal appeal resolution.

What to Include in Your Appeal

• A point-by-point rebuttal of every criterion cited in the denial letter
• Your physician's letter of medical necessity tailored to the specific denial criteria
• Clinical guidelines from specialty societies supporting the treatment
• Evidence that the cost of denial — delayed treatment, disease progression — exceeds the cost of coverage
• For experimental/investigational denials: FDA approval documentation and specialty guideline citations

Fight Back With ClaimBack

Not appealing an insurance denial is one of the most expensive financial decisions you can make. The appeal costs nothing. The potential recovery is thousands to hundreds of thousands of dollars. And the data shows that a significant percentage of appeals succeed — because many initial denials are wrong, algorithmic, or inadequately reviewed. Every dollar you pay out of pocket for a denied claim that could have been overturned is money you did not have to spend. ClaimBack generates a professional appeal letter in 3 minutes, at no cost to you.

Start your free claim analysis →

Free analysis · No credit card required · Takes 3 minutes

Related Reading

• How to Write an Insurance Appeal Letter
• What Is Medical Necessity?
• Internal vs External Insurance Appeal